Healthcare - Drug Manufacturers - General - NYSE - US
$ 164.99
-2.74 %
$ 292 B
Market Cap
57.69
P/E
BALANCE SHEET
135 B
ASSETS
124 B
LIABILITIES
10.4 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
AbbVie Inc.
| Current Assets | 33 B |
| Cash & Short-Term Investments | 12.8 B |
| Receivables | 11.2 B |
| Other Current Assets | 9.03 B |
| Non-Current Assets | 102 B |
| Long-Term Investments | 304 M |
| PP&E | 4.99 B |
| Other Non-Current Assets | 96.4 B |
| Current Liabilities | 37.8 B |
| Accounts Payable | 3.69 B |
| Short-Term Debt | 7.19 B |
| Other Current Liabilities | 27 B |
| Non-Current Liabilities | 86.5 B |
| Long-Term Debt | 53 B |
| Other Non-Current Liabilities | 33.5 B |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Cash & Cash Equivalents | 12 814.0 | 9 201.0 | 9 746.0 | 8 449.0 | 39 924.0 | 7 289.0 | 9 303.0 | 5 100.0 | 8 399.0 | 8 348.0 | 9 595.0 | 5 901.0 | 27.0 | 9.6 | |
| Short Term Investments | 2.0 | 28.0 | 84.0 | 30.0 | 0 | 772.0 | 486.0 | 1 323.0 | 8.0 | 26.0 | 300.0 | 2 075.0 | 626.0 | 1.1 | |
| Receivables | 11 155.0 | 11 254.0 | 9 977.0 | 8 822.0 | 5 428.0 | 5 384.0 | 5 088.0 | 4 758.0 | 4 730.0 | 3 735.0 | 4 803.0 | 4 298.0 | 3 817.0 | 3 373.1 | |
| Inventory | 4 099.0 | 3 579.0 | 3 128.0 | 3 310.0 | 1 813.0 | 1 605.0 | 1 605.0 | 1 444.0 | 1 719.0 | 1 124.0 | 1 150.0 | 1 091.0 | 872.0 | 836.3 | |
| Other Current Assets | 4 932.0 | 4 401.0 | 4 993.0 | 3 562.0 | 2 354.0 | 1 895.0 | 4 741.0 | 3 562.0 | 1 458.0 | 2 848.0 | 2 000.0 | 1 989.0 | 2 012.0 | 3 998.3 | |
| Total Current Assets | 33 002.0 | 28 463.0 | 27 928.0 | 24 173.0 | 49 519.0 | 16 945.0 | 21 223.0 | 16 187.0 | 16 314.0 | 16 081.0 | 17 848.0 | 15 354.0 | 7 354.0 | 8 218.5 | |
| PP&E | 4 989.0 | 4 935.0 | 5 110.0 | 5 248.0 | 2 962.0 | 2 883.0 | 2 803.0 | 2 604.0 | 2 565.0 | 2 485.0 | 2 298.0 | 2 247.0 | 2 144.0 | 2 357.6 | |
| Intangible Assets | 55 610.0 | 67 439.0 | 75 951.0 | 82 876.0 | 18 649.0 | 21 233.0 | 27 559.0 | 28 897.0 | 19 709.0 | 1 513.0 | 1 890.0 | 2 323.0 | 2 910.0 | 3 691.2 | |
| Goodwill | 32 293.0 | 32 156.0 | 32 379.0 | 33 124.0 | 15 604.0 | 15 663.0 | 15 785.0 | 15 416.0 | 13 168.0 | 5 862.0 | 6 277.0 | 6 130.0 | 6 100.0 | 6 197.2 | |
| Long Term Investments | 304.0 | 241.0 | 277.0 | 293.0 | 93.0 | 1 420.0 | 2 090.0 | 1 783.0 | 145.0 | 92.0 | 118.0 | 119.0 | 229.0 | 137.4 | |
| Other Long Term Assets | 8 513.0 | 5 571.0 | 4 884.0 | 4 851.0 | 2 288.0 | 1 208.0 | 1 326.0 | 1 212.0 | 1 149.0 | 1 480.0 | 767.0 | 835.0 | (135.7) | 0 | |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Assets | 134 711.0 | 138 805.0 | 146 529.0 | 150 565.0 | 89 115.0 | 59 352.0 | 70 786.0 | 66 099.0 | 53 050.0 | 27 513.0 | 29 198.0 | 27 008.0 | 19 521.0 | 21 134.7 | |
| LIABILITIES | |||||||||||||||
| Accounts Payable | 3 688.0 | 2 934.0 | 2 882.0 | 2 276.0 | 1 452.0 | 1 546.0 | 1 474.0 | 1 407.0 | 1 597.0 | 1 401.0 | 933.0 | 556.0 | 417.0 | 356.8 | |
| Short Term Debt | 7 191.0 | 4 136.0 | 12 495.0 | 8 502.0 | 3 753.0 | 5 308.0 | 6 415.0 | 402.0 | 2 431.0 | 4 439.0 | 431.0 | 1 042.0 | 16.0 | 0 | |
| Other Current Liabilities | 26 962.0 | 22 468.0 | 19 817.0 | 17 883.0 | 10 380.0 | 10 385.0 | 8 752.0 | 7 972.0 | 6 866.0 | 5 553.0 | 5 515.0 | 5 178.0 | 5 464.0 | 3 404.5 | |
| Total Current Liabilities | 37 841.0 | 29 538.0 | 35 194.0 | 28 661.0 | 15 585.0 | 17 239.0 | 16 641.0 | 9 781.0 | 10 894.0 | 11 393.0 | 6 879.0 | 6 776.0 | 5 897.0 | 3 761.2 | |
| Long Term Debt | 52 956.0 | 59 906.0 | 64 927.0 | 78 407.0 | 63 246.0 | 35 002.0 | 30 953.0 | 36 440.0 | 29 240.0 | 10 538.0 | 14 292.0 | 14 630.0 | 32.0 | 0 | |
| Deferred Tax Income | 0 | 2 190.0 | 3 009.0 | 3 646.0 | 1 130.0 | 1 067.0 | 2 490.0 | 6 890.0 | 5 276.0 | 159.0 | 570.0 | 360.0 | 646.0 | 0 | |
| Other Liabilities | 33 517.0 | 32 074.0 | 30 972.0 | 30 400.0 | 18 456.0 | 15 557.0 | 18 095.0 | 15 242.0 | 8 971.0 | 3 840.0 | 3 535.0 | 1 879.0 | 1 014.0 | 1 185.5 | |
| Total Liabilities | 124 314.0 | 121 518.0 | 131 093.0 | 137 468.0 | 97 287.0 | 67 798.0 | 65 689.0 | 61 463.0 | 49 105.0 | 25 771.0 | 24 706.0 | 23 645.0 | 7 589.0 | 5 431.7 | |
| EQUITY | |||||||||||||||
| Common Stock | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 17.0 | 16.0 | 16.0 | 3 713.0 | 11 957.0 | 0 | |
| Retained Earnings | (1 000.0) | 4 784.0 | 3 127.0 | 1 055.0 | 4 717.0 | 3 368.0 | 5 459.0 | 4 378.0 | 2 248.0 | 535.0 | 1 567.0 | 0 | 0 | 0 | |
| Other Accumulative Comprehensive Income/Loss | (2 305.0) | (2 199.0) | (2 899.0) | (3 117.0) | (3 596.0) | (2 480.0) | (2 727.0) | (2 586.0) | (2 561.0) | (2 031.0) | (442.0) | (350.0) | (25.2) | 288.3 | |
| Total Equity | 10 397.0 | 17 287.0 | 15 436.0 | 13 097.0 | (8 172.0) | (8 446.0) | 5 097.0 | 4 636.0 | 3 945.0 | 1 742.0 | 4 492.0 | 3 363.0 | 11 932.0 | 15 703.0 | |
| Total Liabilities and Equity | 134 711.0 | 138 805.0 | 146 529.0 | 150 565.0 | 89 115.0 | 59 352.0 | 70 786.0 | 66 099.0 | 53 050.0 | 27 513.0 | 29 198.0 | 27 008.0 | 19 521.0 | 21 134.7 | |
| SHARES OUTSTANDING | |||||||||||||||
| Common Shares Outstanding | 1 768.0 | 1 771.0 | 1 770.0 | 1 667.0 | 1 481.0 | 1 541.0 | 1 596.0 | 1 622.0 | 1 625.0 | 1 595.0 | 1 589.0 | 1 577.0 | 1 616.0 | 1 616.0 | 1 616.0 |